GNH USA

Europe — EMA

Nipent (Pentostatin)

GNH USA supplies Nipent (Pentostatin), a purine analog antineoplastic agent for hairy cell leukemia. Request a quote for supply to hospitals worldwide.

Request sourcing

1
Pack/s

What is Pentostatin?

Pentostatin, the active ingredient in Nipent, is a purine analog presented as an injectable solution for intravenous use. It belongs to the antineoplastic agent class and is indicated for the treatment of hairy cell leukemia in adult patients. The drug works by targeting a specific enzyme involved in DNA synthesis, offering a therapeutic option for this rare hematologic malignancy.

GNH USA supplies Nipent as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Pentostatin used for?

Pentostatin is used primarily in the management of hematologic malignancies, especially B‑cell lineage disorders.

Hairy cell leukemia: induces remission and reduces disease burden in affected patients.

What are the side effects of Pentostatin?

Pentostatin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Fatigue: generalized tiredness. - Myelosuppression: reduced blood cell counts increasing infection risk.

Serious or Rare Side Effects: - Severe neutropenia: markedly low neutrophil levels. - Anaphylaxis: acute allergic reaction requiring emergency care. - Pulmonary toxicity: inflammation or fibrosis of lung tissue.

What precautions apply to Pentostatin?

When using Pentostatin, several precautions should be observed to minimize risks. - Monitor blood counts: perform regular CBC to detect myelosuppression. - Assess renal function: adjust use in patients with impaired kidney function. - Avoid live vaccines: immunosuppression may reduce vaccine efficacy. - Use caution in infections: treat active infections before initiating therapy. - Review concomitant myelosuppressive drugs: evaluate additive bone marrow toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Pentostatin interact with?

Pentostatin can interact with other medicines, influencing its safety and effectiveness.

Major Interactions (Avoid): - Allopurinol: may increase toxicity due to overlapping metabolic pathways. - Live attenuated vaccines: risk of uncontrolled infection. - Concurrent myelosuppressive chemotherapy: can cause profound bone marrow suppression.

Moderate Interactions (Monitor Closely): - Azathioprine: may enhance immunosuppressive effects. - Rituximab: combined therapy may increase infection risk. - Cyclophosphamide: additive myelosuppression requiring dose adjustments.

Frequently asked questions

What is Nipent used for?+
Nipent contains the active ingredient Pentostatin and is indicated for the treatment of hairy cell leukemia, a rare B‑cell malignancy. It is used in adult patients to achieve remission by targeting malignant lymphocytes.
How does Pentostatin work?+
Pentostatin inhibits adenosine deaminase, leading to accumulation of deoxyadenosine nucleotides inside lymphoid cells. This interferes with DNA synthesis and repair, causing cell‑cycle arrest and apoptosis of the cancerous B‑cells that drive hairy cell leukemia.
What determines the dose of Nipent?+
The dose of Nipent is individualized by the prescribing physician based on factors such as the patient’s weight, disease severity, renal and hepatic function, and concurrent therapies. No fixed regimen is provided in public literature.
Is Pentostatin safe during pregnancy or breastfeeding?+
Safety data for Pentostatin in pregnancy and lactation are limited, and the product is generally classified as contraindicated or to be used only if the potential benefit justifies the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.
How do I order Nipent from GNH USA?+
To order Nipent, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.
How does Pentostatin compare with other treatments for hairy cell leukemia?+
Pentostatin and cladribine are the two main purine analogues used for hairy cell leukemia. Both achieve high remission rates, but Pentostatin may have a slightly different toxicity profile, with a higher incidence of certain hematologic side effects. Choice of therapy depends on patient‑specific factors and physician judgment.
What are the recommended storage conditions for Nipent?+
Nipent should be stored at 2‑8 °C (refrigerated). Keep the vials in the original packaging, protect them from light, and do not freeze or shake the solution. If temperature excursions occur, consult the supplier before use.
How is Nipent administered?+
Nipent is supplied as an injectable solution for intravenous infusion. Administration is performed by a qualified healthcare professional, typically over a period of several minutes to an hour, depending on the prescribed protocol and patient tolerance.
What are the most serious risks associated with Pentostatin?+
The most serious risks include severe neutropenia leading to life‑threatening infections, anaphylactic reactions, pulmonary toxicity, and significant hemorrhage due to thrombocytopenia. Patients should be monitored closely for signs of infection, bleeding, respiratory distress, or allergic response.
Who should not use Pentostatin?+
Pentostatin should be avoided in patients with known hypersensitivity to the drug, active severe infections, uncontrolled concurrent illnesses, or in those who are pregnant or breastfeeding without a clear benefit. Clinicians must evaluate each individual’s medical history before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Pentostatin
Route
Intravenous Use
Manufacturer
Pfizer Hellas A.E.
Origin
EU

Related products